( As on 16/02/2026 16:00)
Lupin Limited has informed the Exchange regarding a press release dated February 16, 2026, titled ""Lupin Signs License and Supply Agreement with Spektus to Commercialize Novel Antidepressant DeslaFlex in Canada"".